×

img Acces sibility Controls

Technologies Banner

COVID-19 Technology

BBV154 - A novel adenovirus vectored, intranasal vaccine for COVID-19

Implementing Organization

Bharat Biotech Pvt. Ltd., Hyderabad

About

DBT-BIRAC supported India's first Intranasal vaccine to prevent COVID-19 by Bharat Biotech private limited
Funding Organization
Funding Organization

Quick Information
Focus Area
Vaccines, Infectious Diseases
Status
completed
Output in Numbers
Research Paper
00
Technologies (If Any)
00
PhD Produced
N/A
Startup (If Any)
00
Patents
Filed :00
Grant :00
arrowtop